811 related articles for article (PubMed ID: 31801855)
21. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.
Smith CG; Kharkwal H; Wilson DW
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496
[TBL] [Abstract][Full Text] [Related]
22. Discovery of Kaposi's sarcoma herpesvirus-encoded circular RNAs and a human antiviral circular RNA.
Tagawa T; Gao S; Koparde VN; Gonzalez M; Spouge JL; Serquiña AP; Lurain K; Ramaswami R; Uldrick TS; Yarchoan R; Ziegelbauer JM
Proc Natl Acad Sci U S A; 2018 Dec; 115(50):12805-12810. PubMed ID: 30455306
[TBL] [Abstract][Full Text] [Related]
23. Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6.
Hideshima T; Chauhan D; Teoh G; Raje N; Treon SP; Tai YT; Shima Y; Anderson KC
Clin Cancer Res; 2000 Mar; 6(3):1180-9. PubMed ID: 10741750
[TBL] [Abstract][Full Text] [Related]
24. Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 promotes cell proliferation and migration by upregulating DNMT1 via STAT3 activation.
Wu J; Xu Y; Mo D; Huang P; Sun R; Huang L; Pan S; Xu J
PLoS One; 2014; 9(3):e93478. PubMed ID: 24675762
[TBL] [Abstract][Full Text] [Related]
25. Latent infection with Kaposi's sarcoma-associated herpesvirus enhances retrotransposition of long interspersed element-1.
Nakayama R; Ueno Y; Ueda K; Honda T
Oncogene; 2019 May; 38(22):4340-4351. PubMed ID: 30770900
[TBL] [Abstract][Full Text] [Related]
26. Insulin-Like Growth Factor 2 Receptor Expression Is Promoted by Human Herpesvirus 8-Encoded Interleukin-6 and Contributes to Viral Latency and Productive Replication.
Li Q; Chen D; Xiang Q; Nicholas J
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541844
[TBL] [Abstract][Full Text] [Related]
27. Genotypic and clinicopathological characterization of Kaposi's sarcoma-associated herpesvirus infection in Japan.
Kanno T; Sato Y; Nakamura T; Sakamoto K; Sata T; Katano H
J Med Virol; 2010 Mar; 82(3):400-6. PubMed ID: 20087946
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of primary effusion lymphoma engraftment in SCID mice by morpholino oligomers against early lytic genes of Kaposi's sarcoma-associated herpesvirus.
Zhang YJ; Patel D; Nan Y; Fan S
Antivir Ther; 2011; 16(5):657-66. PubMed ID: 21817187
[TBL] [Abstract][Full Text] [Related]
29. Oroxylin A inhibits Kaposi's sarcoma-associated herpes virus (KSHV) vIL-6-mediated lymphatic reprogramming of vascular endothelial cells through modulating PPARγ/Prox1 axis.
Zhu X; Chen Y; Zhu W; Ji M; Xu J; Guo Y; Gao F; Gu W; Yang X; Zhang C
J Med Virol; 2019 Mar; 91(3):463-472. PubMed ID: 30318784
[TBL] [Abstract][Full Text] [Related]
30. Kaposi sarcoma-associated herpesvirus complement control protein (KCP) and glycoprotein K8.1 are not required for viral infection
Muniraju M; Mutsvunguma LZ; Reidel IG; Escalante GM; Cua S; Musonda W; Calero-Landa J; Farelo MA; Rodriguez E; Li Z; Ogembo JG
J Virol; 2024 Jun; 98(6):e0057624. PubMed ID: 38767375
[TBL] [Abstract][Full Text] [Related]
31. Kaposi's sarcoma-associated herpesvirus-encoded viral interleukin-6 is secreted and modified differently than human interleukin-6: evidence for a unique autocrine signaling mechanism.
Meads MB; Medveczky PG
J Biol Chem; 2004 Dec; 279(50):51793-803. PubMed ID: 15258150
[TBL] [Abstract][Full Text] [Related]
32. Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies.
Paul AG; Chandran B; Sharma-Walia N
Transl Res; 2013 Aug; 162(2):77-92. PubMed ID: 23567332
[TBL] [Abstract][Full Text] [Related]
33. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
34. Kaposi's Sarcoma-Associated Herpesvirus Increases PD-L1 and Proinflammatory Cytokine Expression in Human Monocytes.
Host KM; Jacobs SR; West JA; Zhang Z; Costantini LM; Stopford CM; Dittmer DP; Damania B
mBio; 2017 Oct; 8(5):. PubMed ID: 29018115
[TBL] [Abstract][Full Text] [Related]
35. Evidence for Multiple Subpopulations of Herpesvirus-Latently Infected Cells.
Landis JT; Tuck R; Pan Y; Mosso CN; Eason AB; Moorad R; Marron JS; Dittmer DP
mBio; 2022 Feb; 13(1):e0347321. PubMed ID: 35089062
[TBL] [Abstract][Full Text] [Related]
36. Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors.
Carroll PA; Kenerson HL; Yeung RS; Lagunoff M
J Virol; 2006 Nov; 80(21):10802-12. PubMed ID: 16956952
[TBL] [Abstract][Full Text] [Related]
37. Linking the Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to human malignancies.
Kalt I; Masa SR; Sarid R
Methods Mol Biol; 2009; 471():387-407. PubMed ID: 19109790
[TBL] [Abstract][Full Text] [Related]
38. Kaposi's sarcoma-associated herpesvirus vIRF2 protein utilizes an IFN-dependent pathway to regulate viral early gene expression.
Koch S; Damas M; Freise A; Hage E; Dhingra A; Rückert J; Gallo A; Kremmer E; Tegge W; Brönstrup M; Brune W; Schulz TF
PLoS Pathog; 2019 May; 15(5):e1007743. PubMed ID: 31059555
[TBL] [Abstract][Full Text] [Related]
39. The Kaposi's sarcoma-associated herpesvirus viral interleukin 6 gene affects metastasis and expression of B cell markers in a murine xenograft model.
Fullwood RA; Low GM; Chase EP; Grasley M; Beal SS; McCrary IM; Daniels CW; Ingersoll K; Berges BK
PLoS One; 2018; 13(9):e0204947. PubMed ID: 30265712
[TBL] [Abstract][Full Text] [Related]
40. Kaposi's sarcoma herpesvirus (KSHV) microRNA K12-1 functions as an oncogene by activating NF-κB/IL-6/STAT3 signaling.
Chen M; Sun F; Han L; Qu Z
Oncotarget; 2016 May; 7(22):33363-73. PubMed ID: 27166260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
